Every 424B that Nakamoto Inc. (NAKA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow NAKA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NAKA filings page.
Nakamoto Inc. is offering up to $4,993,570,615.16 of Common Stock under an at-the-market sales agreement with multiple agents, registering the remaining capacity under an existing ATM program after prior sales of $6,429,384.84. Sales may be made from time to time through designated agents at market prices or negotiated transactions, with agent commissions up to 2.0% and customary indemnities. The prospectus describes intended uses of net proceeds for general corporate purposes, including pursuit of the company’s Bitcoin Treasury Strategy, and discloses recent M&A, financings and corporate changes including the August 2025 reverse merger, PIPE and debt financings, the February 2026 acquisitions of BTC Inc. and UTXO, and bitcoin holdings of approximately 5,342 BTC valued at $467.5 million as of December 31, 2025.
Nakamoto Inc. (NAKA) registers up to 413,354,801 shares of Common Stock for resale, comprised of up to 351,649,826 resale shares, 61,704,975 pre-funded warrant shares and limited issuances tied to IPO warrants and other previously issued securities. The Company is not selling any shares under this shelf; selling stockholders will sell the registered resale shares and the Company will receive proceeds only from any cash exercise of the registered warrants.
The prospectus states the Company may receive up to $3,725,217.66 from cash exercise of the Registered Warrants and that IPO Warrant exercise depends on the market trading price versus the $6.33 exercise price. The filing warns that substantial resale availability and ATM or other issuances could pressure the market price.
Nakamoto Inc. files a prospectus supplement updating its S-1 to register 2,059,811 shares of common stock issuable upon exercise of previously issued warrants and to provide for resale of 82,310 shares by selling stockholders. The company states it is not selling shares for its own account and will receive proceeds only if the Warrants are exercised for cash. The supplement incorporates the company's Annual Report on Form 10-K, which discloses a strategic pivot from healthcare to a Bitcoin-focused holding and operating model, including the February 20, 2026 acquisitions of BTC Inc and UTXO. The 10-K reports holding approximately 5,342 Bitcoin valued at $467.5 million as of December 31, 2025, and 690,018,254 shares outstanding as of March 23, 2026. The company warns of material risks tied to the Bitcoin strategy and reports a material weakness in internal control over financial reporting.
Nakamoto Inc. files a prospectus supplement registering 2,059,811 shares of common stock issuable upon exercise of previously issued warrants and the resale of 82,310 shares of common stock.
The supplement states the company is not selling any shares and will receive proceeds only if the warrants are exercised for cash. The supplement incorporates a Current Report on Form 8-K describing the completed mergers with BTC and UTXO, the issuance of merger consideration, and updated capitalization: 683,451,950 shares outstanding and 890,148,039 fully diluted shares outstanding as of February 25, 2026.
Nakamoto Inc. has a prospectus supplement covering up to 2,059,811 shares of common stock issuable upon exercise of previously issued warrants and 82,310 shares of common stock for resale. The company is not directly selling shares here; warrant holders and other stockholders may sell their shares using the Prospectus.
Nakamoto will receive cash only if the previously issued tradeable, non-tradeable and representative’s warrants from its June 3, 2024 initial public offering are exercised for cash. The supplement also attaches a Current Report on Form 8-K detailing a First Amendment to a Master Loan Agreement with Payward Interactive, Inc., allowing a designated trading wallet at the lender to be funded and pledged as collateral for both loan obligations and trading activity.
Nakamoto Inc. registers up to 2,059,811 shares of common stock issuable upon exercise of previously issued warrants and 82,310 shares of common stock for resale in a mixed primary and secondary offering. The primary component covers shares underlying tradeable, non-tradeable and representative’s warrants issued in the June 3, 2024 IPO, while the secondary component allows selling stockholders named in the base prospectus to sell their shares from time to time. The company is not directly selling common stock here and will receive no proceeds from investor resales, but may receive cash if outstanding warrants are exercised for cash. The supplement also incorporates recent 8-Ks, including the hiring of experienced finance leaders as Chief Financial Officer and Chief Accounting Officer, and a new 210,000,000 USDT loan from Kraken at an 8.00% annual fee, secured solely by Bitcoin collateral valued at not less than $323.4 million.
Kindly MD, Inc. has filed a prospectus supplement covering the potential issuance of up to 2,059,811 shares of common stock upon exercise of previously issued tradeable, non-tradeable and representative warrants from its initial public offering, plus the resale of 82,310 existing shares by selling stockholders. The company is not selling any common stock itself, so all sale proceeds from resales will go to the warrant holders and selling stockholders, while the company would receive cash only if the warrants are exercised. The supplement also incorporates the company’s most recent Quarterly Report on Form 10-Q into the existing S-1 prospectus. Kindly MD’s common stock trades on Nasdaq under “NAKA” and its tradeable warrants under “NAKAW.”
KindlyMD, Inc. filed a 424B7 prospectus listing numerous named selling stockholders who may offer shares of Common Stock registered for resale under the registration statement. The document states the applicable percentage figures are calculated using 413,603,091 shares of Common Stock outstanding as of September 24, 2025. The filing clarifies that the post-offering share amounts assume (a) all Common Stock underlying the Convertible Notes registered in this statement are sold and (b) no other transactions occur before completion of the offering, but also notes each selling stockholder may sell all, some or none of the shares and may use other registration statements or exemptions such as Rule 144.